Despite a lack of information regarding the association of SDC2 and the EMT in breast cancer, SDC2 emerges as a promising candidate with a relevant function in this context since its expression seems to be higher in mesenchymal than epithelial tissues [72]. This evidence concerns the gene SDC2 and breast cancer.